Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma

International Orthopaedics

Volumn 35, Issue 10, 2011, Pages 1529-1536

  Funovics, Philipp T ^a   Edelhauser, Gundula ^a   Funovics, Martin A ^a   Laux, Christoph ^a   Berzaczy, Dominik ^a   Kubista, Bernd ^a   Kotz, Rainer I ^a   Dominkus, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BONE PROSTHESIS; BONE REMODELING; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS INFECTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL; SURVIVAL TIME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUSTRIA; BONE NEOPLASMS; C-REACTIVE PROTEIN; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; PREOPERATIVE PERIOD; PROGNOSIS; PROSTHESIS-RELATED INFECTIONS; SURGICAL WOUND INFECTION; SURVIVAL RATE; YOUNG ADULT;

EID: 80755172146     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-011-1208-8     Document Type: Article

References (35)

1. DC Dahlin MB Coventry 1967 Osteogenic sarcoma-a study of six hundred cases J Bone Joint Surg Am 49 101 110 5225072 1:STN:280:DyaF2s%2FlslOrug%3D%3D
2. SS Bielack B Kempf-Bielack G Delling, et al. 2002 Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols J Clin Oncol 20 776 790 11821461 10.1200/JCO.20.3.776 (Pubitemid 34111386)
3. G Bacci A Longhi M Versari M Mercuri A Briccoli P Picci 2006 Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution Cancer 106 1154 1161 16421923 10.1002/cncr.21724
4. JA Lee MS Kim DH Kim, et al. 2009 Risk stratification based on the clinical factors at diagnosis is closely related to the survival of localized osteosarcoma Pediatr Blood Cancer 52 340 345 19021220 10.1002/pbc.21843
5. AM Davis RS Bell PJ Goodwin 1994 Prognostic factors in osteosarcoma: a critical review J Clin Oncol 12 423 431 8113851 1:STN:280:DyaK2c7lslKhsQ%3D%3D (Pubitemid 24056419)
6. JA Bramer JH van Linge RJ Grimer RJ Scholten 2009 Prognostic factors in localized extremity osteosarcoma: a systematic review Eur J Surg Oncol 35 1030 1036 19232880 1:STN:280:DC%2BD1Mnhs1Kgtw%3D%3D
7. EE Pakos AD Nearchou RJ Grimer, et al. 2009 Prognostic factors and outcomes for osteosarcoma: an international collaboration Eur J Cancer 45 2367 2375 19349163 10.1016/j.ejca.2009.03.005
8. K Trieb R Kotz 2001 Proteins expressed in osteosarcoma and serum levels as prognostic factors Int J Biochem Cell Biol 33 11 17 11167128 10.1016/S1357-2725(00)00066-2 1:CAS:528:DC%2BD3MXpslyjsw%3D%3D (Pubitemid 32146463)
9. JC Clark CR Dass PF Choong 2008 A review of clinical and molecular prognostic factors in osteosarcoma J Cancer Res Clin Oncol 134 281 297 17965883 10.1007/s00432-007-0330-x 1:CAS:528:DC%2BD1cXhtFert7o%3D (Pubitemid 351170066)
10. LM Jeys RJ Grimer SR Carter RM Tillman A Abudu 2007 Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol 14 2887 2895 17653803 10.1245/s10434-007-9483-8 1:STN:280:DC%2BD2srmtVyntw%3D%3D (Pubitemid 47460646)
11. JA Lee MS Kim DH Kim, et al. 2009 Postoperative infection and survival in osteosarcoma patients Ann Surg Oncol 16 147 151 18979137 10.1245/s10434-008- 0184-8
12. L Marnell C Mold TW Du Clos 2005 C-reactive protein: ligands, receptors and role in inflammation Clin Immunol 117 104 111 16214080 10.1016/j.clim.2005. 08.004 1:CAS:528:DC%2BD2MXhtVyms7vE (Pubitemid 41407719)
13. SD Deodhar 1989 C-reactive protein: the best laboratory indicator available for monitoring disease activity Cleve Clin J Med 56 126 130 2659202 1:STN:280:DyaL1M3nsFCntg%3D%3D (Pubitemid 19168214)
14. C Gabay I Kushner 1999 Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 448 454 9971870 10.1056/NEJM199902113400607 1:STN:280:DyaK1M7it1KhtA%3D%3D (Pubitemid 29084777)
15. I Jialal S Devaraj SK Venugopal 2004 C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44 6 11 15148294 10.1161/01.HYP. 0000130484.20501.df 1:CAS:528:DC%2BD2cXltVSqt7w%3D (Pubitemid 38823477)
16. S Devaraj U Singh I Jialal 2009 The evolving role of C-reactive protein in atherothrombosis Clin Chem 55 229 238 19095731 10.1373/clinchem.2008.108886 1:CAS:528:DC%2BD1MXhvVWks74%3D
17. I Kushner D Rzewnicki D Samols 2006 What does minor elevation of C-reactive protein signify? Am J Med 119 166 e17 e28 16443421
18. K Heikkilä S Ebrahim DA Lawlor 2007 A systematic review of the association between circulating concentrations of C reactive protein and cancer J Epidemiol Community Health 61 824 833 17699539 10.1136/jech.2006.051292 (Pubitemid 47311721)
19. CS Wang CF Sun 2009 C-reactive protein and malignancy: clinico-pathological association and therapeutic implication Chang Gung Med J 32 471 482 19840504
20. G Woeste C Müller WO Bechstein C Wullstein 2010 Increased serum levels of C-reactive protein precede anastomotic leakage in colorectal surgery World J Surg 34 140 146 19953248 10.1007/s00268-009-0304-z
21. W Haupt W Hohenberger R Mueller P Klein NV Christou 1997 Association between preoperative acute phase response and postoperative complications Eur J Surg 163 39 44 9116110 1:STN:280:DyaK2s7otVGrtA%3D%3D (Pubitemid 27062350)
22. T Pfitzner D Krocker C Perka G Matziolis 2008 C-reactive protein. An independent risk factor for the development of infection after primary arthroplasty Orthopade 37 1116 1120 18813908 10.1007/s00132-008-1342-1 1:STN:280:DC%2BD1cjjsVKnsQ%3D%3D
23. LM Jeys RJ Grimer SR Carter RM Tillman 2005 Periprosthetic infection in patients treated for an orthopaedic oncological condition J Bone Joint Surg Am 87 842 849 15805215 10.2106/JBJS.C.01222 1:STN:280:DC%2BD2M7ntlejtA%3D%3D (Pubitemid 40489362)
24. KE Piper M Fernandez-Sampedro KE Steckelberg, et al. 2010 C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection PLoS ONE 5 e9358 20179760 10.1371/journal.pone.0009358
25. M Salzer-Kuntschik G Brand G Delling 1983 Determination of the degree of morphological regression following chemotherapy in malignant bone tumors Pathologe 4 135 141 6576329 1:STN:280:DyaL3s3ntlegsw%3D%3D (Pubitemid 13027617)
26. MS Kim SY Lee TR Lee, et al. 2009 Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma Ann Oncol 20 955 960 19153123 10.1093/annonc/mdn723 1:STN:280:DC%2BD1MzgvVyhtQ%3D%3D
27. L Kager A Zoubek U Kastner, et al. 2006 Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group J Clin Oncol 24 1535 1541 16575004 10.1200/JCO.2005.04.2978 (Pubitemid 46638775)
28. MS Kim SY Lee WH Cho, et al. 2008 Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients Ann Surg Oncol 15 906 914 18163171 10.1245/s10434-007-9779-8
29. JA Bramer AA Abudu RJ Grimer SR Carter RM Tillman 2007 Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer 43 1944 1951 17698347 10.1016/j.ejca.2007.07.004 1:STN:280: DC%2BD2svpvFynug%3D%3D (Pubitemid 47284871)
30. MS Kim SY Lee TR Lee, et al. 2009 Prognostic effect of pathologic fracture in localized osteosarcoma: a cohort/case controlled study at a single institute J Surg Oncol 100 233 239 19294672 10.1002/jso.21265
31. T Nedelcu B Kubista A Koller, et al. 2008 Livin and Bcl-2 expression in high-grade osteosarcoma J Cancer Res Clin Oncol 134 237 244 17632732 10.1007/s00432-007-0276-z 1:CAS:528:DC%2BD2sXhsVSls7fJ (Pubitemid 350234069)
32. K Trieb R Lehner T Stulnig I Sulzbacher KR Shroyer 2003 Survivin expression in human osteosarcoma is a marker for survival Eur J Surg Oncol 29 379 382 12711293 1:STN:280:DC%2BD3s7pt1eitw%3D%3D (Pubitemid 36675696)
33. K Trieb R Gerth G Holzer JG Grohs P Berger R Kotz 2000 Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy Br J Cancer 82 85 87 10638971 10.1054/bjoc.1999.0881 1:CAS:528:DC%2BD3cXltFWltA%3D%3D (Pubitemid 30008963)
34. T Nozoe H Saeki K Sugimachi 2001 Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma Am J Surg 182 197 201 11574097 10.1016/S0002-9610(01)00684-5 1:CAS:528:DC%2BD3MXntV2htL8%3D (Pubitemid 32907362)
35. LA Hefler N Concin G Hofstetter, et al. 2008 Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer Clin Cancer Res 14 710 714 18245530 10.1158/1078-0432.CCR-07-1044 1:CAS:528:DC%2BD1cXhsFyktr0%3D (Pubitemid 351231151)